Successfully Treated Roseomonas mucosa-induced Peritonitis Diagnosed by Mass Spectrometry.

Tomoyuki Nariyama, Yasuko Ito, Koji Fujita, Takafumi Ito, Hiroyuki Terawaki

Abstract readCase Reports

In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Phenotypic and genomic characterization ofAntimicrobial agents and chemotherapy · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomoyuki NariyamaDivision of Nephrology, Department of Internal Medicine, Teikyo University Chiba Medical Center, Japan.

Yasuko ItoDivision of Nephrology, Department of Internal Medicine, Teikyo University Chiba Medical Center, Japan.

Koji FujitaDepartment of Laboratory, Teikyo University Chiba Medical Center, Japan.

Takafumi ItoDivision of Nephrology, Department of Internal Medicine, Teikyo University Chiba Medical Center, Japan.

Hiroyuki TerawakiDivision of Nephrology, Department of Internal Medicine, Teikyo University Chiba Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Roseomonas mucosa is difficult to identify using routine analytical techniques. We herein report a case of peritoneal dialysis (PD)-related peritonitis caused by R. mucosa identified using matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry (MS). A 70-year-old woman was admitted to our hospital with PD-related peritonitis. Blood agar medium of dialysate culture derived colony pale pink in color, and the organism was identified as R. mucosa using MALDI-TOF MS. She was successfully treated with ciprofloxacin and meropenem without catheter removal. To our knowledge, this is the first case of R. mucosa peritonitis in which technique failure has been avoided.

Indexed as

CiprofloxacinMethylobacteriaceaePeritonitisSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAgedAnti-Bacterial AgentsFemaleGram-Negative Bacterial InfectionsHumansMeropenemPeritoneal DialysisThienamycinsTreatment OutcomeAnti-Bacterial AgentsCiprofloxacinMeropenemThienamycinsMADLI-TOFmass spectrometryperitoneal dialysisperitonitisRoseomonas

Identifiers

PMID38220190

DOI10.2169/internalmedicine.2998-23

PMCPMC11414375

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.